relative to data collection and reporting requirements of the prescription drug affordability board.

HB 645 requires the Prescription Drug Affordability Board to establish a formal agreement (MOU) with the Department of Health and Human Services and other state agencies for sharing data. This bill directly affects the Board and state agencies by mandating that agencies share requested data to help the Board fulfill its duties, while minimizing duplicate data collection. Key provisions include modifying existing MOUs where possible, requiring agencies to release data upon request, and including cost-sharing terms in the agreement. The bill streamlines data access without creating new drug pricing policies or altering the Board’s core responsibilities.